Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 11/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32669323 | 0.82 | PIKFYVE (0.61) | GAAMAPTHTTALDH1A1AKR1C3 | |
| SCHEMBL32669402 | 0.80 | LMNA (0.49) | GAAMAPTHTTALDH1A1AKR1C3 | |
| SCHEMBL32669339 | 0.78 | PIK3CA (0.48) | GAAMAPTHTTNPSR1PKM | |
| SCHEMBL32669392 | 0.77 | MAPT (0.47) | GAAMAPTHTTNPSR1ALDH1A1 | |
| SCHEMBL32669325 | 0.76 | GAA (0.65) | GAAHPGDMAPTHTTNPSR1 | |
| SCHEMBL32669196 | 0.76 | MAPT (0.67) | GAAMAPTHTTNPSR1PKM | |
| SCHEMBL22737369 | 0.75 | GAA (0.59) | GAAHPGDMAPTHTTNPSR1 | |
| SCHEMBL32669258 | 0.75 | GAA (0.57) | GAAHPGDMAPTHTTNPSR1 | |
| SCHEMBL425033 | 0.75 | TYK2 (0.62) | GAAHPGDMAPTHTTALDH1A1 | |
| SCHEMBL425032 | 0.75 | TYK2 (0.62) | GAAHPGDMAPTHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034141-A1 | METHODS AND COMPOSITIONS FOR TREATING MALIGNANT CANCERS | 6J BIOTECHNOLOGY HONG KONG LTD (HK) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034141-A1 | METHODS AND COMPOSITIONS FOR TREATING MALIGNANT CANCERS | MCL1, GLI1, BECN1 | GAA 1558/4885HPGD 3950/4885MAPT 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.